The earnings call revealed a decline in revenue and cash reserves, with increased R&D expenses. Despite some positive aspects, such as reduced cost of goods sold, the lack of clear guidance and the management's evasive responses in the Q&A raise concerns. The absence of a strong catalyst or partnership announcement, combined with financial pressures, suggests a negative outlook for the stock price.
